Rapid conversion to sirolimus for chronic progressive deterioration of the renal function in kidney allograft recipients
- 19 June 2003
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 35 (4) , 1292-1294
- https://doi.org/10.1016/s0041-1345(03)00375-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination1, 2Transplantation, 2002
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- SIROLIMUS ALLOWS EARLY CYCLOSPORINE WITHDRAWAL IN RENAL TRANSPLANTATION RESULTING IN IMPROVED RENAL FUNCTION AND LOWER BLOOD PRESSURE1,2,10Transplantation, 2001
- CONVERSION TO RAPAMYCIN IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTS: REPORT OF AN INITIAL EXPERIENCE1Transplantation, 2000
- SIROLIMUS (RAPAMYCIN) HALTS AND REVERSES PROGRESSION OF ALLOGRAFT VASCULAR DISEASE IN NON-HUMAN PRIMATES1Transplantation, 2000
- Neointimal Formation After Balloon-Induced Vascular Injury in Yucatan Minipigs is Reduced by Oral RapamycinJournal of Cardiovascular Pharmacology, 1999
- Current thinking on chronic renal allograft rejection: Issues, concerns, and recommendations from a 1997 roundtable discussionAmerican Journal of Kidney Diseases, 1999
- HISTOPATHOLOGIC FINDINGS FROM 2-YEAR PROTOCOL BIOPSIES FROM A U.S. MULTICENTER KIDNEY TRANSPLANT TRIAL COMPARING TACROLIMUS VERSUS CYCLOSPORINETransplantation, 1998